Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin

被引:21
作者
Das, Nilanjana [1 ]
Madan, Parshotam [1 ]
Lin, Senshang [1 ]
机构
[1] St Johns Univ, Coll Pharm & Allied Hlth Profess, Queens, NY USA
关键词
Basal insulin; Pluronic F-127; buccal; statistical optimization; IN-VITRO EVALUATION; SUSTAINED-RELEASE; POLOXAMER; 407; STABILITY; VEHICLES; SYSTEMS; DESIGN; SALTS; F127;
D O I
10.3109/10837450.2010.542164
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The principle of statistical optimization was employed to fabricate insulin-loaded Pluronic F-127 (PF-127) gel formulations having the potential for buccal delivery of basal insulin. A two-level resolution III fractional factorial design was applied to simultaneously evaluate five independent formulation variables: PF-127 concentration, insulin concentration, sodium sulfate concentration, hydroxypropylmethyl cellulose (HPMC) concentration, and presence of sodium glycocholate. The amount of insulin released and permeated from gels as well as gelation time and mucoadhesion force of gels were measured and used as dependent response variables for formulation optimization. Optimization of a gel formulation was achieved by applying constrained optimization via regression analysis. In vitro permeation flux of insulin from the optimized formulation through procine buccal mucosa was 93.17 (+/- 0.058, n = 3) mu g/cm(2). Plasma insulin levels following buccal administration of the optimized formulation at 10, 25 and 50 IU/kg to healthy rats were found to be dose dependent and basal insulin levels were maintained at least for 8 h. Furthermore, continuous hypoglycemia for at least 8 h was observed with 89%, 51% and 25% of blood glucose reduction, respectively, for these three doses. The results of this investigation conclude the feasibility of development of optimized buccal insulin-loaded Pluronic F-127 gels for basal insulin delivery.
引用
收藏
页码:363 / 374
页数:12
相关论文
共 37 条
[1]  
AUNGST BJ, 1988, J PHARMACOL EXP THER, V244, P23
[2]   Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407 [J].
Bhardwaj, R ;
Blanchard, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (09) :915-919
[3]  
CANABA A, 1997, J COLLOID INTERF SCI, V190, P307
[4]   Development of in situ gelling and mucoadhesive acetaminophen liquid suppository [J].
Choi, HG ;
Jung, JH ;
Ryu, JM ;
Yoon, SJ ;
Oh, YK ;
Kim, CK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (01) :33-44
[5]  
Das N, 2010, PHARM DEV TECHNOL, V15, P192, DOI [10.1080/10837450903085442, 10.3109/10837450903085442]
[6]   In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine [J].
Desai, SD ;
Blanchard, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (02) :226-230
[7]   In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate [J].
El-Kamel, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :47-55
[8]  
Fonseca V., 2006, Insulin, V1, P51
[9]   New developments in insulin delivery [J].
Ghilzai, NMK .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (03) :253-265
[10]  
Goddard ED, 1993, INTERACTIONS SURFACT, P171